Pathstone Holdings, LLC Axsome Therapeutics, Inc. Transaction History
Pathstone Holdings, LLC
- $22.3 Billion
- Q3 2024
A detailed history of Pathstone Holdings, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Pathstone Holdings, LLC holds 3,843 shares of AXSM stock, worth $374,192. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,843
Previous 3,767
2.02%
Holding current value
$374,192
Previous $303,000
13.86%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AXSM
# of Institutions
324Shares Held
37.7MCall Options Held
797KPut Options Held
747K-
Rtw Investments, LP New York, NY4.19MShares$408 Million6.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4MShares$389 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$321 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$230 Million34.46% of portfolio
-
Bvf Inc San Francisco, CA1.05MShares$102 Million2.99% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.18B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...